Market Closed -
Sao Paulo
04:07:48 2024-04-26 pm EDT
5-day change
1st Jan Change
25.62
BRL
+2.69%
+0.67%
-12.86%
Raia Drogasil S A : Presentation - RD Day 2022
November 03, 2022 at 08:23 am EDT
09:00 Opening
Antônio Carlos
Pipponzi
09:10 Company
Overview
Marcílio Pousada
09:25 New Pharmacy,
Operations, Omni
and Pharma
Services
Renato Raduan
09:50 New Pharmacy and Marketplacce
Vitor Bertoncini, Juliana
Lopes & Fernando Varela
10:25 Q&A
10:40 Health Hub Vitat
Bruno Pipponzi
10:50 Digital
Transformation
11:00 People and
Culture
Maria Susana de Souza
11:10 Market Vision, and Perspectives for 2023
Eugênio De Zagottis
11:35 Q&A
12:00 Closing
Opening
Antonio Carlos
Pipponzi
Chairman of the Board
Company
Overview
Marcilio Pousada
CEO
By 2014 we launched the " North II Project"
But not all goals were assertive or achieved
5
01 02 03 04 05 06 07 08 Company Overview
This is an excerpt of the original content. To continue reading it, access the original document here .
Attachments
Original Link
Original Document
Permalink
Disclaimer
Raia Drogasil SA published this content on 03 November 2022 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 03 November 2022 12:22:02 UTC .
Transcript : Raia Drogasil S.A., Q4 2023 Earnings Call, Mar 06, 2024
Mar. 06
Raia Drogasil S.A. Reports Earnings Results for the Full Year Ended December 31, 2023
Mar. 04
CI
Raia Drogasil S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Mar. 04
CI
Transcript : Raia Drogasil S.A., Q3 2023 Earnings Call, Nov 01, 2023
Nov. 01
Brazil's Rd Reports Q3 Adjusted EBITDA Of 658.1 Million Reais
23-10-31
RE
Raia Drogasil S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
23-10-30
CI
Transcript : Raia Drogasil S.A., Q2 2023 Earnings Call, Aug 09, 2023
23-08-09
Raia Drogasil S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
23-08-07
CI
Transcript : Raia Drogasil S.A., Q1 2023 Earnings Call, May 03, 2023
23-05-03
Raia Drogasil S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-05-01
CI
Transcript : Raia Drogasil S.A., Q4 2022 Earnings Call, Mar 08, 2023
23-03-08
Brazil's RD posts 47% increase in Q4 adjusted net profit
23-03-07
RE
Raia Drogasil S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022
23-03-06
CI
Raia Drogasil S.A. Reports Earnings Results for the Full Year Ended December 31, 2022
23-03-06
CI
Transcript : Raia Drogasil S.A., Q3 2022 Earnings Call, Nov 01, 2022
22-11-01
Raia Drogasil S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
22-10-30
CI
Transcript : Raia Drogasil S.A., Q2 2022 Earnings Call, Aug 01, 2022
22-08-01
Raia Drogasil S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
22-07-29
CI
Brazil's Raia Drogasil posts 48% increase in Q2 adjusted net profit
22-07-29
RE
Transcript : Raia Drogasil S.A., Q1 2022 Earnings Call, May 04, 2022
22-05-04
Raia Drogasil S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022
22-05-02
CI
Raia Drogasil S.A.(BOVESPA:RADL3) added to Brazil IBRX 50 Index
22-05-02
CI
Transcript : Raia Drogasil S.A., Q4 2021 Earnings Call, Feb 23, 2022
22-02-23
Brazil's Raia Drogasil posts Q4 net profit of 187 mln reais
22-02-22
RE
Raia Drogasil S.A. Reports Earnings Results for the Full Year Ended December 31, 2021
22-02-21
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Raia Drogasil S.A. specializes in the distribution of medicines, cosmetics and dermocosmetics, perfumery, personal care and beauty products. Net sales break down by family of products as follows:
- branded pharmaceuticals (42%);
- pharmaceutical additives (25.1%) ;
- OTC products (21.3%);
- generic pharmaceutical products (11.4%).
At the end of 2020, its products were marketed through a network of 2,299 pharmacies under the Drogasil (1,304) and Raia (995) brands in Brazil.
More about the company
Last Close Price
25.62
BRL
Average target price
30.93
BRL
Spread / Average Target
+20.73%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1